FPH.NZ
FPH.NZ
NZFAPE0001S2
Fisher & Paykel Healthcare Corp
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 100/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±27.9% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Largely moves in line with the broader market.

Beta (Market Relation)
0.88x
Defensive
Volatility (5Y p.a.)
27.9% p.a.
5-Year Horizon
Max Drawdown (5Y)
-46.4%
5-Year Horizon
Sharpe Ratio
0.27
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +26.9%
3 Years 26.6% -21.5% 1.02 +29.4%
5 Years 27.9% -46.4% 0.27 +9.5%
10 Years 29.0% -52.0% 0.49 +16.9%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 59.6 (Elevated multiple compression risk)
Historical Stress Test: Maximum peak-to-trough drawdown of -52.0% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
5 ISS Score: 5 / 10
Audit Risk
5 ISS Score: 5 / 10
Board Risk
4 ISS Score: 4 / 10
Short Ratio
-
ende